The role of β‐barrels 1 and 2 in the enzymatic activity of factor XIII A‐subunit

ISTH Academy, Helen Philippou, 226175

A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH

ISTH Academy, Hideo Wada, 226176

Role of von Willebrand factor and ADAMTS‐13 in early brain injury after experimental subarachnoid hemorrhage

ISTH Academy, Mervyn Vergouwen, 226177

Correction of a dominant‐negative von Willebrand factor multimerization defect by small interfering RNA‐mediated allele‐specific inhibition of mutant von Willebrand factor

ISTH Academy, Jeroen Eikenboom, 226179

Extended International Normalized Ratio testing intervals for warfarin‐treated patients

ISTH Academy, Geoffrey Barnes, 226180

Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies

ISTH Academy, Keiji Nogamimi, 226181

A new redox switch regulating von Willebrand factor activity

ISTH Academy, Renhao Li, 226182

Flow cytometric analysis of extracellular vesicle subsets in plasma: impact of swarm by particles of non‐interest

ISTH Academy, Sten Libregts, 226183

A systematic review and Bayesian network meta‐analysis of risk of intracranial hemorrhage with direct oral anticoagulants

ISTH Academy, Zachary Wolfe, 226184

Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort

ISTH Academy, Sigrid Braekkan, 226185

Four times cancer

ISTH Academy, Session Speakers, 226186

Stay Coagulated and Join the ISTH Today

ISTH Academy, Session Speakers, 226187

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia

ISTH Academy, Ishac Nazi, 226188

Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: reply

ISTH Academy, Sarah Takach Lapner, 226189

Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: comment

ISTH Academy, Noémie Kraaijpoel, 226190

Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey: comment

ISTH Academy, Ole H. Olsen, 226191

Issue Information

ISTH Academy, Session Speakers, 226192

Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer

ISTH Academy, Cynthia Wu, 226193

Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis

ISTH Academy, Lakshman Vasanthamohan, 226194

Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study

ISTH Academy, Theodore Spiro, 226195

A comparative analysis of different automated von Willebrand factor glycoprotein Ib‐binding activity assays in well typed von Willebrand disease patients

ISTH Academy, Inge Vangenechten, 226196

Hemostasis biomarkers and incident cognitive impairment: the REGARDS study

ISTH Academy, Mary Cushman, 226197

Prediction of short‐term prognosis in elderly patients with acute pulmonary embolism: validation of the RIETE score

ISTH Academy, Tobias Tritschler, 226198

What the neighbors say

ISTH Academy, Session Speakers, 226199

Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH

ISTH Academy, Margaret Ragni, 226200

Subtype‐specific clinical and prognostic relevance of tumor‐expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study

ISTH Academy, Mari Tinholt, 226201

Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta‐analysis

ISTH Academy, Marcello Di Nisio, 226202

Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey: reply

ISTH Academy, Teguh Widjajadi, 226203

Preventing Post-Thrombotic Syndrome

ISTH Academy, Susan Kahn & Akhilesh Sista, 210957

Hemostasis: Emerging Therapies

ISTH Academy, Jim Munn & Kate Khair, 219028

Karl Landsteiner

ISTH Academy, Session Speakers, 219349

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe hemorrhage

ISTH Academy, Michael Desborough, 219350

Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation

ISTH Academy, Frank Coumans, 219351

Platelets loaded with liposome‐encapsulated thrombin have increased coagulability

ISTH Academy, Christian J. Kastrup, 219352

Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets

ISTH Academy, Yuanjie Yu, 219353

Use of direct oral anticoagulants in antiphospholipid syndrome

ISTH Academy, Hannah Cohen, 219354

Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor

ISTH Academy, Beate Kehrel, 219355

Issue Information

ISTH Academy, Session Speakers, 219356

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

ISTH Academy, Cihan Ay, 219357

Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study

ISTH Academy, Pieter W. Kamphuisen, 219358

Bacterial killing by platelets: making sense of (H)IT

ISTH Academy, Marc F. Hoylaerts, 219359

Recombinant factor XIII A‐subunit in a patient with factor XIII deficiency and recurrent pregnancy loss

ISTH Academy, Murtadha Al‐Khabori, 219360

Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism

ISTH Academy, Frederikus Klok, 219361

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab

ISTH Academy, Keiji Nogamimi, 219362

Effect of rosuvastatin on risk markers for venous thromboembolism in cancer

ISTH Academy, Steven Ades, 219363

Outcomes following a negative computed tomography pulmonary angiography according to pulmonary embolism prevalence: a meta‐analysis of the management outcome studies

ISTH Academy, Steve Provencher, 219364

Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review

ISTH Academy, Johanna van der Bom, 219365

Stabilization of warfarin‐binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition

ISTH Academy, Weikai Li, 219366

Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response

ISTH Academy, Vivien Chen, 219367

What the neighbor says

ISTH Academy, Session Speakers, 219368

Professor Gustav Victor Rudolph Born (29 July 1921 – 16 April 2018)

ISTH Academy, Session Speakers, 219369

Comparative analysis of marketed factor VIII products: recombinant products are not alike vis‐a‐vis soluble protein aggregates and subvisible particles

ISTH Academy, Julia Anzengruber, 219370

PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway

ISTH Academy, Matthew Rondina, 219371

Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8‐GP) and development of a human pharmacokinetic prediction model

ISTH Academy, Frederik Rode, 219372

Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH

ISTH Academy, Correspondence |Dr. Marc Carrier, 219373

Stay Coagulated and Join the ISTH Today

ISTH Academy, Session Speakers, 219374

Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA

ISTH Academy, Andreas Greinacher, 219375

Mechanisms of enhanced thrombin‐generating capacity in patients with cirrhosis

ISTH Academy, Ton Lisman, 219376

Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis

ISTH Academy, Thomas Sinegre, 219377

Staphylococcus aureus‐induced complement activation promotes tissue factor‐mediated coagulation

ISTH Academy, Tom Eirik Mollnes, 219451

Risk of early‐onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum

ISTH Academy, Joel G. Ray, 219452

Age‐adjusted D‐dimer cut‐off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays

ISTH Academy, Maria Farm, 219453

Retinoic acid receptor‐α regulates synthetic events in human platelets: reply

ISTH Academy, Hansjorg Schwertz, 219454

Platelet packing density is an independent regulator of the hemostatic response to injury

ISTH Academy, Maurizio Tomaiuolo, 219455

Sex‐specific performance of pre‐imaging diagnostic algorithms for pulmonary embolism

ISTH Academy, Thijs Van Mens, 219456

Basic weapons to degrade C3a and C5a

ISTH Academy, Jonathan H. Foley, 219457

Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses

ISTH Academy, Cecile Vindis, 219458

Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations: comment

ISTH Academy, Raphaël Marlu, 219459

What a drag: necrotic platelets induce remote neutrophil thrombi following ischemic gut injury

ISTH Academy, Kimberly Martinod, 219460

Stay Coagulated and Join the ISTH Today

ISTH Academy, Session Speakers, 219461

Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC‐2/podoplanin‐dependent platelet aggregation and lung metastasis

ISTH Academy, Katsue Suzuki-Inoue, 219462

Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz‐1 domain

ISTH Academy, Helle Petersen, 219463

Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice

ISTH Academy, John Morser, 219464

Retinoic acid receptor‐α regulates synthetic events in human platelets: comment

ISTH Academy, Henri de la Salle, 219465

Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women

ISTH Academy, Laura B. Harrington, 219466

What the neighbors say

ISTH Academy, Session Speakers, 219467

Efficacy, safety and pharmacokinetics of a new high‐purity factor X concentrate in women and girls with hereditary factor X deficiency

ISTH Academy, Miranda Norton, 219468

Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants

ISTH Academy, Sophie Testa, 219469

The chaperone protein HSP47: a platelet collagen binding protein that contributes to thrombosis and hemostasis

ISTH Academy, Parvathy Sasikumar, 219470

Lots and lots of women

ISTH Academy, Session Speakers, 219471

An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH

ISTH Academy, Marlien Pieters, 219472

An international collaborative study to calibrate the WHO 2nd International Standard for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin (15/140): communication from the SSC of the ISTH

ISTH Academy, Craig Thelwell, 219473

Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation

ISTH Academy, Cecilia Becattini, 219474

Issue Information

ISTH Academy, Session Speakers, 219475

The plasminogen receptor Plg‐R is essential for mammary lobuloalveolar development and lactation

ISTH Academy, R. J. Parmer, 219476

Platelet function testing: dead or alive

ISTH Academy, Amin Polzin, 219477

Auto‐ and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences

ISTH Academy, Laszlo Muszbek, 219478

Glycoprotein VI in securing vascular integrity in inflamed vessels

ISTH Academy, Benoit Ho-Tin-Noé, 219323

Fibrinogen concentrations predict long‐term cognitive outcome in young ischemic stroke patients

ISTH Academy, Annie Pedersen, 219324

Prevention and treatment of the post‐thrombotic syndrome

ISTH Academy, Arina Ten Cate-Hoek, 219325

Proteolytic processing of platelet receptors

ISTH Academy, Elizabeth Gardiner, 219326

Galectin‐3 in venous thrombosis: A possible new target for improved patient care

ISTH Academy, Jose Antonio Diaz, 219327

The coagulation system in atherothrombosis: Implications for new therapeutic strategies

ISTH Academy, Renske Olie, 219328

Product type and other environmental risk factors for inhibitor development in severe hemophilia A

ISTH Academy, Flora Peyvandi, 219329

Effects of daily aspirin on cancer incidence and mortality in the elderly Japanese

ISTH Academy, Kenji Yokoyama, 219339

Characteristics of pain, other symptoms and function in pediatric post‐thrombotic syndrome

ISTH Academy, Leonardo Brandao, 219340

Search engine optimization: What is it and why should we care?

ISTH Academy, Session Speakers, 219341

Update on the electrolytic IVC model for pre‐clinical studies of venous thrombosis

ISTH Academy, Jose Antonio Diaz, 219342

Antigenic binding sites of anti‐protein S autoantibodies in patients with recurrent pregnancy loss

ISTH Academy, Toshitaka Sugi, 219343

Current and future burden of venous thrombosis: Not simply predictable

ISTH Academy, Suzanne Cannegieter, 219344